Computational validation complete
From a genome-scale metabolic model to 16 chip-eligible strains, a structurally modeled optogenetic valve, and a cross-species proof point — every computational phase is done and covered by a filed provisional patent. Two biophysical gates come next.
10,440
KO combinations screened
16
Chip-eligible strains
2
Species validated
Filed
US provisional 64/087,071
iJDZ836 Genome-Scale Metabolic Model
The iJDZ836 model (836 genes, ~1,200 reactions) provides a comprehensive picture of N. crassa metabolism. Full flux-balance analysis predicted growth across 78 candidate carbon sources and quantified the metabolic impact of every knockout combination before any wet-lab work.
| Model Property | Value |
|---|---|
| Total genes modeled | 836 |
| Metabolic reactions | ~1,200 |
| Carbon sources tested | 78 |
| Carbon sources supporting growth | 24 |
| Permissive chow source | Xylose |
| Pairwise KO combinations | 10,440 |
Key finding: Of 78 carbon sources, only 24 support growth. Xylose is selected as the permissive chow feed — knockouts then block the common reagent sugars while preserving xylose utilization, the basis of metabolic orthogonality.
Wild-type predicted growth by carbon source, normalized to xylose
These are wild-type predictions. The engineered chassis blocks the reagent sugars shown here while preserving xylose utilization.
Wild-type predicted growth, normalized to xylose. Not the engineered chassis.
Screening Funnel
16 Chip-Eligible Strains
From 10,440 pairwise knockout combinations across a 145-gene pool, each pair was ranked by the Composite Orthogonality Score (COS). Sixteen pairs clear the chip-integration threshold of RBS ≥ 0.868 — these are the chassis candidates that can colonize a chip while blocking reagent metabolism.
Composite Orthogonality Score
COS = √( CPS × RBS )
CPS (Chow Preservation Score) measures retained xylose growth. RBS (Reagent Block Score) = 1 − (reagent growth ÷ WT xylose growth). The geometric mean rewards pairs that block reagents and stay alive on chow.
Exemplary Chip-Eligible Pair
A central-glycolysis enzyme knockout paired with a respiratory-chain subunit knockout — strong reagent blocking with enough residual xylose growth to colonize.
0.185
CPS
0.868
RBS
~18.5%
Residual xylose vs WT
COS Tradeoff — CPS vs RBS
X: Chow Preservation (CPS) · Y: Reagent Blocking (RBS) · ● 16 chip-eligible (RBS ≥ 0.868)
Honest constraint: no pair reaches the upper-right corner — none achieves both CPS > 0.5 and RBS > 0.8 at once. This is an inherent biological tradeoff: deeper reagent blocking costs chow fitness. The 16 chip-eligible strains are the best available balance.
The Six-Gene Chassis
A chip-eligible pair is only the metabolic core. The full chassis layers in four more knockouts for kinetics, morphology, and optogenetic isolation — six engineered edits that together make a clean, light-controllable fluidic network.
Central glycolysis enzyme
Knocked out to break glucose-route flux — forces dependence on the xylose chow feed.
Respiratory-chain subunit
Paired knockout that deepens reagent blocking while preserving residual xylose growth.
Carbon-catabolite-repression regulator
Removed to lift repression on xylose utilization — a kinetic growth benefit on the chow source.
Aerial-hyphae suppressor (i)
Keeps growth confined to the channel plane so the network stays a clean fluidic conduit.
Aerial-hyphae suppressor (ii)
Second morphology control that reinforces channel integrity during colonization.
Blue-light photoreceptor
Removed so the native light response cannot interfere transcriptionally with the 450 nm optogenetic valve.
Validated in a Second Species
Metabolic orthogonality is a platform strategy, not a one-organism trick. The same approach was re-run in silico on Aspergillus nidulans using the published iMA871 model (871 genes) — a fungus separated from N. crassa by roughly 170 million years of evolution.
Orthologous knockouts (a sugar transporter + a central-carbon aldolase, identified by reciprocal BLASTP) reproduce the xylose-selective phenotype — and actually block reagents more strongly than the N. crassa equivalent.
| A. nidulans double KO | Result |
|---|---|
| Growth on xylose | 0.198 h⁻¹ (27% WT) |
| Growth on glucose | 0.031 h⁻¹ (4.2% WT) |
| Reagent blocking | 95.8% |
| CPS | 0.270 |
| RBS | 0.958 |
| COS | 0.508 |
Why it matters: A. nidulans clears the chip-integration threshold (RBS 0.958) where N. crassa falls short — direct evidence the strategy generalizes and the addressable organism set is broad.
Composite Orthogonality Score
Reagent Block Score: 0.958
Reagent Block Score: 0.75
Evolutionary Distance
N. crassa
A. nidulans
Two genera, ~170M years apart — the same orthogonality phenotype is reachable in both.
ColabFold Structural Modeling
Both valve components were predicted with ColabFold (AlphaFold2-based). pLDDT scores above 80 on the functional domains indicate the individual domains are predicted to fold as intended.
What pLDDT does and does not tell us
pLDDT is per-domain confidence. It says each domain is likely to fold correctly; it does not address whether the two components bind each other. Our construct presents the binding motif through an internal linker rather than at a free C-terminus, departing from canonical PDZ geometry, and multimer prediction of the lit-state complex returned an inconclusive ipTM of 0.18. The binding geometry is the open question, and it is what Gate 2 measures.
91
LOV2 domain
Very high
88
HEX1 domain
Very high
76
Jα helix
Flexible hinge
| Construct | Size | pLDDT | Key structural feature |
|---|---|---|---|
| CompA_v3 (LOV2-HEX1 plug) | 334 aa · 36.9 kDa | 91 | LOV2 β-sheet + Jα helix intact |
| CompB (SPA1-ePDZ anchor) | 358 aa · 39.4 kDa | 88 | PDZ binding groove correctly folded |
Next step: SEC-MALS (M4) confirms the oligomeric state of CompA_v3 with target R_h ≥ 28 nm, followed by BLI/SPR binding confirmation (M6) targeting K_d ≤ 1 µM in the lit state.
pLDDT Confidence Scale
The functional domains score 91 and 88 — both "very high". The Jα helix scores 76, exactly as expected for a flexible photoswitching hinge.
CompA_v3 Domain Architecture (N→C)
from Avena sativa phototropin 1
binds ePDZ in the lit state
~16 aa Gly-Ser
Woronin-body pore-occluding domain
N-terminal LOV2 placement leaves the HEX1 C-terminal crystal contacts free to self-assemble — verified by structural superposition (6.5 Å clearance).
Both gates clear before any chassis or chip work
This ordering is deliberate: strain engineering is the expensive step, and there is no reason to spend it before the valve protein is known to behave. Work downstream of the gates is shown greyed because it is contingent on them.
SEC-MALS on CompA_v3
Mw ≥ 1000 kDa, Mw/Mn < 1.5 (R_h ≥ 28 nm)
Gate — must clear
BLI/SPR — Jα motif to ePDZ anchor
K_d ≤ 1 µM lit, ≥10× dark/lit contrast
Gate — must clear
Six-gene chassis construction
PCR-verified knockouts
Valve function in hypha (microscopy)
Reversible reduction in cross-septal transport at 450 nm
Prototype chip colonization
Fluorescent flow through network
First academic beta site
LOI from 3 labs
Publications & intellectual property
Forthcoming
McKenna, M. "Robustness of Fungal Circuits."
Fungal Biology and Biotechnology (forthcoming, 2026).
Submitted
McKenna, M. "Tiered regulatory flux balance analysis identifies carbon catabolite repression as the limiting constraint on xylose-selective strain design in Neurospora crassa."
Submitted to Fungal Genetics and Biology.
Preprint
McKenna, M. Preprint on the metabolic gene screening platform.
SSRN.
Intellectual Property
US provisional application 64/087,071, filed June 10, 2026, covering the metabolically orthogonal chassis, the optogenetic septal pore valve, the H-tree scaffold geometry, and the screening method. Michael McKenna is sole applicant and the application is owned outright with no institutional encumbrance.
Competing interests: the author is the sole applicant on the patent application covering the methods and compositions described in this work and has a direct financial interest in their commercialization.